Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
1,765.00    -13.00 (-0.73%)
Bid:
1,768.00
Ask:
1,771.00
Spread: 3.00 (0.17%)
Market Cap: £1.98b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Planning Consent

29 Feb 2008 07:01

Derwent London PLC29 February 2008 29 February 2008 Derwent London plc ("Derwent London"/ "Company") DERWENT LONDON SECURES PLANNING FOR MIDTOWN OFFICE SCHEME Derwent London, one of London's most dynamic and innovative property investorsand developers, is pleased to announce that the City of London has resolved togrant planning permission for the redevelopment of 40-45 Chancery Lane, WC2which currently comprises three multi let buildings totalling 71,146 sq ft(6,610 sq m). Designed by Bennetts Associates, the proposals are for a development of 102,900sq ft (9,556 sq m) of high quality office .The key focus of the design is acentral courtyard which will be built at the rear of the scheme linking the newspace to a building which is being retained in Tooks Court. In addition, therewill be retail space fronting Chancery Lane. The scheme will be a welcome addition to Derwent London's growing portfolio ofstylish office accommodation in the Midtown area, building on the successfulrefurbishment and lettings at the Johnson Building in Hatton Garden in 2007.Located in a rapidly expanding and vibrant part of London, Chancery Lane furtherdemonstrates the Company's confidence in an area which it believes continues tooffer occupiers significant rental value. Nigel George, Director at Derwent London, commented: "The scheme was well researched to achieve divisible floorplates which willappeal to a wide range of occupiers, together with a private courtyard offeringtenants attractive break out spaces. "The proposals are in line with Derwent London's passion for high qualityoffices that will appeal to prospective tenants looking to base themselves inthis increasingly popular area." -ends- For further information please contact: Dido Laurimore/Nicole Marino, Financial Dynamics (for Derwent London): Tel: 020 7831 3113 Nigel George, Director, Derwent London Tel 020 7659 3000 Notes to editors Derwent London plc Derwent London plc was formed on 1 February 2007 following the merger of DerwentValley Holdings and London Merchant Securities and converted to REIT status on 1July 2007. The group is one of London's most innovative office specialistproperty developers and investors and is well known for its establisheddesign-led philosophy and creative management approach to development. DerwentLondon won the RIBA Client of the Year Award 2007. Derwent London's core strategy is to acquire and own a portfolio of CentralLondon property that has reversionary rents and significant opportunities toenhance and extract value through refurbishment and redevelopment. The groupowns and manages an investment portfolio of over £2.8 billion, of which £2.5billion or 93% is located in Central London, with a specific focus on the WestEnd and the areas bordering the City of London. Landmark schemes by DerwentLondon include: Qube W1, Johnson Building EC1, Davidson Building WC2 andBroadwick House W1. Approximately 50% of the London portfolio is identified as having theopportunity, through development, to achieve significant gains in floor areaand, thereby, increases in value. The existing pipeline of development andrefurbishment projects is extensive, totalling 3.3 million sq ft (306,500 sq m). This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Jun 20262:00 pmRNSHolding(s) in Company
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20265:37 pmRNSTotal Voting Rights
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20265:15 pmRNSDirector/PDMR Shareholding
19th May 202610:00 amRNSDirector Declaration
18th May 20267:00 amRNSTransaction in Own Shares
15th May 202611:45 amRNSResult of AGM
12th May 20267:00 amRNSTrading Statement
1st May 202610:30 amRNSHolding(s) in Company
30th Apr 20264:45 pmRNSTotal Voting Rights
22nd Apr 20265:00 pmRNSHolding(s) in Company
22nd Apr 202610:15 amRNSHolding(s) in Company
20th Apr 202610:30 amRNSHolding(s) in Company
14th Apr 202611:14 amRNSAnnual Financial Report
10th Apr 20264:45 pmRNSAdmission to Trading
7th Apr 20265:12 pmRNSEmployee Benefit Trust (“EBT”)
7th Apr 20264:45 pmRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSAppointment of Barclays as joint corporate broker
1st Apr 20267:00 amRNSDisposal of Horseferry House SW1
31st Mar 20264:45 pmRNSTotal Voting Rights
27th Mar 202612:45 pmRNSDirector/PDMR Shareholding
24th Mar 202610:30 amRNSDirector/PDMR Shareholding
20th Mar 20264:15 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSNetwork building fully pre-let
16th Mar 20267:00 amRNSNetwork building fully pre-let
27th Feb 20264:45 pmRNSTotal Voting Rights
26th Feb 20267:32 amRNSDerwent London plc Disposal of 90 Whitfield Street
26th Feb 20267:00 amRNSResults for the Year Ended 31 December 2025
6th Feb 20264:40 pmRNSHolding(s) in Company
6th Feb 20267:00 amRNSDisposal of 80-85 Tottenham Court Road W1
30th Jan 20264:45 pmRNSTotal Voting Rights
22nd Jan 20269:00 amRNSDirectorate change
15th Jan 202611:00 amRNSHolding(s) in Company
31st Dec 20251:15 pmRNSTotal Voting Rights
31st Dec 20251:15 pmRNSTotal Voting Rights
17th Dec 20257:00 amRNSPlanning success at Blue Star House SW9
9th Dec 20257:00 amRNSBurberry extends commitment to Horseferry House
28th Nov 20254:45 pmRNSTotal Voting Rights
6th Nov 20257:00 amRNSThird Quarter Business Update
31st Oct 20254:45 pmRNSTotal Voting Rights
21st Oct 20257:00 amRNSStrategic partnership at Old Street Quarter
9th Oct 20257:00 amRNSSuccessful completion of 25 Baker Street
30th Sep 20254:45 pmRNSTotal Voting Rights
30th Sep 202511:00 amRNSHolding(s) in Company
22nd Sep 202512:00 pmRNSBlock listing Interim Review
9th Sep 202511:45 amRNSDirector Declaration
2nd Sep 202511:30 amRNSHolding(s) in Company
29th Aug 20254:45 pmRNSTotal Voting Rights
12th Aug 20257:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.